Company: LHI
Filing Date: 2025-05-23
Form Type: F-1
Source: 0001213900-25-046955
Chunk: 231

Company: Living Homeopathy International Ltd.
Filing Date: 2025-05-23
Form: F-1
Chunk 231
---
, and will not be, lodged with the Australian Securities                                                                       
 and Investments Commission, or the ASIC, as a disclosure document for the purposes of the Corporations Act and does not purport to include 
 the information required of a disclosure document under Chapter 6D.2 of the Corporations Act;                                              |

| ● | does not constitute or involve a recommendation to acquire,                                                                           
 an offer or invitation for issue or sale, an offer or invitation to arrange the issue or sale, or an issue or sale, of interests to a 
 “retail client” (as defined in section 761G of the Corporations Act and applicable regulations) in Australia; and                     |

| ● | may only be provided in Australia to select investors who are                                                                          
 able to demonstrate that they fall within one or more of the categories of investors, or Exempt Investors, available under section 708 
 of the Corporations Act.                                                                                                               |

The Class A Ordinary Shares may not be directly
or indirectly offered for subscription or purchased or sold, and no invitations to subscribe for or buy the Class A Ordinary Shares may
be issued, and no draft or definitive offering memorandum, advertisement or other offering material relating to any Class A Ordinary Shares
may be distributed in Australia, except where disclosure to investors is not required under Chapter 6D of the Corporations Act or
is otherwise in compliance with all applicable Australian laws and regulations. By submitting an application for the Class A Ordinary
Shares, you represent and warrant to us that you are an Exempt Investor.

As any offer of Class A Ordinary Shares under
this prospectus will be made without disclosure in Australia under Chapter 6D.2 of the Corporations Act, the offer of those securities
for resale in Australia within 12 months may, under section 707 of the Corporations Act, require disclosure to investors under
Chapter 6D.2 if none of the exemptions in section 708 applies to that resale. By applying for the Class A Ordinary Shares you
undertake to us that you will not, for a period of 12 months from the date of issue of the Class A Ordinary Shares, offer, transfer,
assign or otherwise alienate those securities to investors in Australia except in circumstances where disclosure to investors is not required
under Chapter 6D.2 of the Corporations Act or where a compliant disclosure document is prepared and lodged with ASIC.

<div align='center'>133</div>

Notice to Prospective Investors in Canada

Resale restrictions.The distribution of
the